跳至主要内容
临床试验/NCT04277507
NCT04277507已完成不适用

A Prospective, Multicenter Study of the AERin Medical Vivaer® ARC Stylus for Nasal AirWAY Obstruction (AERWAY)

Aerin Medical19 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2020年2月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
122
试验地点
19
主要终点
Change in Nasal Obstructive Symptom Evaluation (NOSE) Scores From Baseline to 3 Months

研究概览

简要总结

Post-market study to continue to evaluate the effectiveness of the Vivaer® ARC Stylus for nasal airway obstruction

详细描述

Prospective, Multicenter, Non-randomized Study of the Aerin Medical Vivaer® ARC Stylus for Nasal Airway Obstruction to continue to evaluate the effectiveness of the Vivaer® ARC Stylus for treating the nasal valve area to improve symptoms in those diagnosed with nasal airway obstruction.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 or older
  • Willing and able to provide informed consent
  • Willing and able to comply with the study protocol
  • Seeking treatment for nasal obstruction
  • NOSE score of ≥ 60 at Baseline
  • Nasal valve is a primary or significant contributor to the subject's nasal obstruction as determined by the study investigator (based on clinical presentation, physical examination, nasal endoscopy, etc.) and the subject has a positive response to any of the following temporary measures (based on patient history or office exam):
  • Use of external nasal dilator strips (e.g., Breathe Right Strips)
  • Q-Tip test (manual intranasal lateralization)
  • Use of nasal stents
  • Cottle Maneuver (manual lateral retraction of the cheek)

排除标准

  • Prior surgical treatment of the nasal valve
  • Rhinoplasty, septoplasty, inferior turbinate reduction or other surgical nasal procedures within the past three (3) months
  • Anatomy that requires an adjunctive surgical nasal procedure on the same day or 3 months after the Vivaer procedure
  • Medical conditions which in the opinion of the treating physician would predispose the subject to poor wound healing or increased surgical risk.

结局指标

主要结局

Change in Nasal Obstructive Symptom Evaluation (NOSE) Scores From Baseline to 3 Months

时间窗: 3 Month

Mean change in NOSE score from Baseline to 3 months.Scores may range from the best score of 0, meaning no nasal obstructive symptoms to the worst score of 100, meaning severe nasal obstructive symptoms.

次要结局

未报告次要终点

研究者

发起方
Aerin Medical
申办方类型
Industry
责任方
Sponsor

研究点 (19)

Loading locations...

相似试验